Jodi Warman Chardon

Dr. Jodi Warman Chardon - NMD4C investigator and steering committee member

Clinician-Scientist, Director of the Ottawa Neuromuscular Centre, The Ottawa Hospital; Associate Scientist, OHRI; Scientist, CHEORI

Associate Professor of Neurology, Co-Director of the Centre for Neuromuscular Disease, University of Ottawa

NMD4C Involvement: Pillar 2: Clinical Research, Theme 5: Open Science

Email Jodi


Dr. Jodi Warman Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease and Associate Professor of Neurology at University of Ottawa. She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She is also co-director (with Dr Robin Parks) of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers.

Dr. Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University.  She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG).

Dr. Warman’s clinical research focuses on improved genomic and imaging studies for patients with inherited myopathies and neuromuscular disorders. She represents adult NMDs as a member of the NMD4C Steering Committee and will ensure that the next generation of NMD scientists and clinicians is engaged in all activities of the work plan. She participates in genomics education for the network, leading on engaging trainees and early-career researchers.

Recent Publications

Warman-Chardon, J, Breiner, A, Bourque, PR. Inclusion body myositis. CMAJ. 2024.196 (14)E486 PMID:38621777

Esteller, D, Schiava, M, Verdú-Díaz, J, Villar-Quiles, RN, Dibowski, B, Venturelli, N et al.. Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis. J Neurol. 2024.271 (4)2147-2148 PMID:38349561

Donkervoort, S, Mohassel, P, O'Leary, M, Bonner, DE, Hartley, T, Acquaye, N et al.. Recurring homozygous ACTN2 variant (p.Arg506Gly) causes a recessive myopathy. Ann Clin Transl Neurol. 2024.11 (3)629-640 PMID:38311799

Warman-Chardon, J, Hartley, T, Marshall, AE, McBride, A, Couse, M, Macdonald, W et al.. Biallelic SOX8 Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian Dysfunction. Neurol Genet. 2023.9 (5)e200088 PMID:38235364

Leduc-Pessah, H, Smith, IC, Kernohan, KD, Sampaio, M, Melkus, G, Strasser, L et al.. Congenital tremor and myopathy secondary to novel MYBPC1 variant. J Neurol Sci. 2024.457 122864 PMID:38185014

See more on PubMed